DO COMORBIDITIES INCREASE THE RISK OF FAILURE TO REACH REMISSION IN EARLY RHEUMATOID ARTHRITIS PATIENTS RECEIVING METHOTREXATE AS FIRST-LINE THERAPY?

被引：0
|
作者：
Tidblad, L. [1 ]
Westerlind, H. [1 ]
Delcoigne, B. [1 ]
Askling, J. [1 ]
Saevarsdottir, S. [1 ,2 ]
机构：
[1] Karolinska Inst, Div Clin Epidemiol, Dept Med, Stockholm, Sweden
[2] Univ Iceland, Sch Hlth Sci, Fac Med, Reykjavik, Iceland
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Comorbidities; Rheumatoid arthritis; Remission;
D O I：
10.1136/annrheumdis-2023-eular.2684
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0031
引用
收藏
页码：222 / 223
页数：2
相关论文
共 50 条
  • [1] Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide study
    Tidblad, Liselotte
    Westerlind, Helga
    Delcoigne, Benedicte
    Askling, Johan
    Saevarsdottir, Saedis
    [J]. RMD OPEN, 2023, 9 (04):
  • [2] AUTOANTIBODY STATUS IS NOT ASSOCIATED WITH EARLY TREATMENT RESPONSE TO FIRST-LINE METHOTREXATE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
    Dekkerst, J. S.
    Bergstra, S. A.
    Chopra, A.
    Tikly, M.
    Fonseca, J. E.
    Salomon-Escoto, K.
    Huizinga, T.
    van der Woude, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 843 - 844
  • [3] Autoantibody status is not associated with early treatment response to first-line methotrexate in patients with early rheumatoid arthritis
    Dekkers, Jacqueline S.
    Bergstra, Sytske Anne
    Chopra, Arvind
    Tikly, Mohammed
    Fonseca, Joao Eurico
    Salomon-Escoto, Karen
    Huizinga, Tom W. J.
    van der Woude, Diane
    [J]. RHEUMATOLOGY, 2019, 58 (01) : 149 - 153
  • [4] First-line Therapy with Etanercept for Patients with Early-Stage Rheumatoid Arthritis
    Lorenz, Judith
    [J]. AKTUELLE RHEUMATOLOGIE, 2020, 45 (04)
  • [5] Should methotrexate be a first-line treatment for rheumatoid arthritis?
    Wilke, WS
    [J]. CLEVELAND CLINIC JOURNAL OF MEDICINE, 1999, 66 (04) : 207 - 208
  • [6] A PREDICTION MODEL THAT IDENTIFIES PATIENTS MOST LIKELY TO BENEFIT FROM FIRST-LINE THERAPY WITH ADALIMUMAB PLUS METHOTREXATE IN EARLY RHEUMATOID ARTHRITIS
    van Vollenhoven, R. F.
    Betts, K.
    Signorovitch, J.
    Bao, C.
    Shaw, J. W.
    Ganguli, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 480 - 480
  • [7] Remission Induction Therapy with Methotrexate and Prednisone in Patients with Early Rheumatoid and Undifferentiated Arthritis.
    Wevers-de Boer, K. V. C.
    Heimans, L.
    Visser, K.
    Ronday, H. K.
    Molenaar, T. H. E.
    Seys, P. E. H.
    Bijkerk, C.
    Westedt, M. L.
    De Beus, W.
    de Sonnaville, P. B.
    Huizinga, T.
    Allaart, C. F.
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S167 - S168
  • [8] THE IMPORTANCE OF TREATMENT STRATEGY FOR THE OUTCOME OF EARLY RHEUMATOID ARTHRITIS PATIENTS NOT RESPONDERS TO THE FIRST LINE THERAPY WITH METHOTREXATE
    Fedele, Anna Laura
    Tolusso, Dario Bruno Barbara
    Petricca, Luca
    Ferraccioli, Gianfranco
    Gremese, Elisa
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1578 - 1579
  • [9] Cost-effectiveness of Triple Therapy vs. Biologic Treatment Sequence as First-line Therapy for Rheumatoid Arthritis Patients after Methotrexate Failure
    Li, SiNi
    Li, JianHe
    Peng, LiuBao
    Li, YaMin
    Wan, XiaoMin
    [J]. RHEUMATOLOGY AND THERAPY, 2021, 8 (02) : 775 - 791
  • [10] Cost-effectiveness of Triple Therapy vs. Biologic Treatment Sequence as First-line Therapy for Rheumatoid Arthritis Patients after Methotrexate Failure
    SiNi Li
    JianHe Li
    LiuBao Peng
    YaMin Li
    XiaoMin Wan
    [J]. Rheumatology and Therapy, 2021, 8 : 775 - 791
12345